245.12
price up icon0.15%   0.36
 
loading
前日終値:
$244.76
開ける:
$245.15
24時間の取引高:
562.70K
Relative Volume:
0.54
時価総額:
$35.94B
収益:
$5.02B
当期純損益:
$1.31B
株価収益率:
27.51
EPS:
8.91
ネットキャッシュフロー:
$1.56B
1週間 パフォーマンス:
-0.15%
1か月 パフォーマンス:
+3.10%
6か月 パフォーマンス:
-1.57%
1年 パフォーマンス:
+19.01%
1日の値動き範囲:
Value
$243.64
$246.24
1週間の範囲:
Value
$242.22
$247.48
52週間の値動き範囲:
Value
$179.42
$263.05

Resmed Inc Stock (RMD) Company Profile

Name
名前
Resmed Inc
Name
セクター
Healthcare (1177)
Name
電話
(858) 746-2400
Name
住所
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA
Name
職員
9,980
Name
Twitter
@resmed
Name
次回の収益日
2024-10-24
Name
最新のSEC提出書
Name
RMD's Discussions on Twitter

RMD を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Medical Instruments & Supplies icon
RMD
Resmed Inc
245.12 36.00B 5.02B 1.31B 1.56B 8.91
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
555.75 194.50B 8.71B 2.48B 1.75B 6.82
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
173.82 49.39B 20.87B 1.50B 2.59B 5.24
Medical Instruments & Supplies icon
ALC
Alcon Inc
86.35 42.61B 9.93B 1.12B 1.58B 2.25
Medical Instruments & Supplies icon
COO
The Cooper Companies, Inc.
79.96 15.86B 3.93B 415.40M 384.70M 2.06

Resmed Inc Stock (RMD) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-03-19 開始されました Morgan Stanley Overweight
2025-01-16 開始されました Goldman Buy
2025-01-10 開始されました Piper Sandler Neutral
2024-12-13 開始されました Stifel Hold
2024-09-24 開始されました Robert W. Baird Outperform
2024-09-18 ダウングレード Wolfe Research Peer Perform → Underperform
2024-09-04 ダウングレード Needham Buy → Hold
2024-06-25 ダウングレード Oppenheimer Outperform → Perform
2024-06-24 ダウングレード Citigroup Buy → Neutral
2024-02-06 再開されました KeyBanc Capital Markets Overweight
2023-10-27 アップグレード Morgan Stanley Equal-Weight → Overweight
2023-10-12 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2023-10-09 アップグレード JP Morgan Neutral → Overweight
2023-09-29 ダウングレード Wolfe Research Outperform → Peer Perform
2023-09-06 アップグレード Needham Hold → Buy
2023-09-05 ダウングレード UBS Buy → Neutral
2023-08-01 アップグレード RBC Capital Mkts Sector Perform → Outperform
2023-05-23 開始されました UBS Buy
2023-04-14 開始されました Mizuho Buy
2023-01-17 アップグレード JP Morgan Neutral → Overweight
2022-10-28 ダウングレード Citigroup Buy → Neutral
2022-10-20 アップグレード BofA Securities Neutral → Buy
2022-10-12 開始されました Jefferies Hold
2022-09-08 アップグレード Citigroup Neutral → Buy
2022-08-15 ダウングレード CLSA Buy → Outperform
2022-08-12 ダウングレード Citigroup Buy → Neutral
2022-08-12 ダウングレード JP Morgan Overweight → Neutral
2022-08-12 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2022-06-06 アップグレード RBC Capital Mkts Sector Perform → Outperform
2022-04-06 開始されました Wolfe Research Outperform
2022-01-31 アップグレード Citigroup Neutral → Buy
2022-01-31 アップグレード Goldman Neutral → Buy
2022-01-28 アップグレード RBC Capital Mkts Underperform → Sector Perform
2022-01-24 アップグレード BofA Securities Underperform → Neutral
2022-01-24 アップグレード JP Morgan Neutral → Overweight
2022-01-13 アップグレード CLSA Outperform → Buy
2022-01-13 アップグレード Robert W. Baird Neutral → Outperform
2021-12-21 アップグレード KeyBanc Capital Markets Sector Weight → Overweight
2021-12-06 アップグレード Macquarie Neutral → Outperform
2021-10-22 アップグレード CLSA Underperform → Outperform
2021-08-02 ダウングレード CLSA Outperform → Sell
2021-08-02 ダウングレード Needham Buy → Hold
2021-07-28 アップグレード Jefferies Underperform → Hold
2021-07-26 ダウングレード JP Morgan Overweight → Neutral
2021-07-14 開始されました RBC Capital Mkts Underperform
2021-06-28 ダウングレード Citigroup Buy → Neutral
2021-06-22 アップグレード Macquarie Neutral → Outperform
2021-06-22 開始されました Robert W. Baird Neutral
2021-06-21 繰り返されました Needham Buy
2021-06-16 ダウングレード BofA Securities Neutral → Underperform
2021-06-09 アップグレード CLSA Sell → Outperform
2021-05-21 アップグレード JP Morgan Neutral → Overweight
2021-05-11 アップグレード Citigroup Neutral → Buy
2021-04-30 ダウングレード Citigroup Buy → Neutral
2021-03-16 アップグレード Needham Hold → Buy
2020-11-02 アップグレード UBS Neutral → Buy
2020-10-30 アップグレード JP Morgan Underweight → Neutral
2020-10-27 アップグレード BofA Securities Underperform → Neutral
2020-08-07 ダウングレード Morgan Stanley Overweight → Equal-Weight
2020-06-17 アップグレード Morgan Stanley Equal-Weight → Overweight
2020-05-01 ダウングレード JP Morgan Neutral → Underweight
2020-05-01 アップグレード Oppenheimer Perform → Outperform
2020-02-18 ダウングレード Morgan Stanley Overweight → Equal-Weight
2020-02-03 開始されました CLSA Underperform
2020-01-31 ダウングレード UBS Buy → Neutral
2020-01-10 開始されました Oppenheimer Perform
2019-11-22 開始されました KeyBanc Capital Markets Sector Weight
2019-07-29 アップグレード UBS Neutral → Buy
2019-07-16 ダウングレード UBS Buy → Neutral
2019-05-06 アップグレード UBS Neutral → Buy
2019-04-18 アップグレード JP Morgan Underweight → Neutral
2019-01-25 ダウングレード Goldman Buy → Neutral
2019-01-25 ダウングレード JP Morgan Neutral → Underweight
2018-10-26 アップグレード Credit Suisse Neutral → Outperform
2018-07-02 開始されました Goldman Buy
すべてを表示

Resmed Inc (RMD) 最新ニュース

pulisher
May 29, 2025

ResMed Inc. Files Conflict Minerals Disclosure Report for 2024 - TipRanks

May 29, 2025
pulisher
May 28, 2025

Actigraphy Devices Market Report 2025-2034 | Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape - GlobeNewswire Inc.

May 28, 2025
pulisher
May 27, 2025

ResMed CFO Executes Stock Transaction Under Rule 10b5-1 Plan - TipRanks

May 27, 2025
pulisher
May 27, 2025

ResMed CFO Brett Sandercock sells $891,285 in stock By Investing.com - Investing.com South Africa

May 27, 2025
pulisher
May 27, 2025

Hedge Fund and Insider Trading News: Bill Ackman, Paul Tudor Jones, Chase Coleman, John Paulson, Polus Capital Management, VFC Corp (VFC), ResMed Inc (RMD), and More - Insider Monkey

May 27, 2025
pulisher
May 27, 2025

ResMed CFO Brett Sandercock sells $891,285 in stock - Investing.com

May 27, 2025
pulisher
May 24, 2025

ResMed’s SWOT analysis: sleep tech giant faces growth challenges, new markets - Investing.com

May 24, 2025
pulisher
May 23, 2025

ResMed (RMD) Up 4% Since Last Earnings Report: Can It Continue? - Yahoo Finance

May 23, 2025
pulisher
May 23, 2025

Are Wall Street Analysts Bullish on ResMed Stock? - Inkl

May 23, 2025
pulisher
May 23, 2025

Are Wall Street Analysts Bullish On ResMed Stock? - Barchart.com

May 23, 2025
pulisher
May 23, 2025

Is it Worth Retaining ResMed Stock in Your Portfolio Now? - Nasdaq

May 23, 2025
pulisher
May 23, 2025

Insider Sell: Witte De Sells 2,000 Shares of ResMed Inc (RMD) - GuruFocus

May 23, 2025
pulisher
May 22, 2025

ResMed CFO Sells Shares - marketscreener.com

May 22, 2025
pulisher
May 22, 2025

Why Kogan, Monash IVF, OFX, and ResMed shares are falling today - MSN

May 22, 2025
pulisher
May 22, 2025

Down 5%: What's going on with the ResMed share price? - MSN

May 22, 2025
pulisher
May 21, 2025

RMD ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of ResMed Inc. Shareholders Who Lost Money - ACCESS Newswire

May 21, 2025
pulisher
May 21, 2025

Morgan Stanley sees ‘modest’ earnings impact to ResMed from Apnimed - Yahoo Finance

May 21, 2025
pulisher
May 21, 2025

Should you buy the dip in the ResMed share price? - MSN

May 21, 2025
pulisher
May 20, 2025

ResMed Draws Analyst Skepticism After Apnimed Announces Positive Results From Investigational Sleep Apnea Drug: Retail’s Unmoved By Stocktwits - Investing.com India

May 20, 2025
pulisher
May 20, 2025

ResMed Draws Analyst Skepticism After Apnimed Announces Positive Results From Investigational Sleep Apnea Drug: Retail’s Unmoved - MSN

May 20, 2025
pulisher
May 20, 2025

Positive Phase 3 Trial Results for RMD's Sleep Apnea Treatment | - GuruFocus

May 20, 2025
pulisher
May 20, 2025

ResMed (RMD) Faces Potential Market Challenges from New Sleep Ap - GuruFocus

May 20, 2025
pulisher
May 20, 2025

ResMed (RMD) Faces Potential Market Challenges from New Sleep Apnea Treatment | RMD Stock News - GuruFocus

May 20, 2025
pulisher
May 19, 2025

Here's Why ResMed (RMD) is a Strong Growth Stock - Yahoo Finance

May 19, 2025
pulisher
May 18, 2025

ResMed (NYSE:RMD) Seems To Use Debt Rather Sparingly - simplywall.st

May 18, 2025
pulisher
May 15, 2025

Apnea Therapy Market Is Booming Worldwide 2025-2032 | ResMed Inc., Koninklijke Philips N.V. - openPR.com

May 15, 2025
pulisher
May 15, 2025

Resmed (RMD) Partners with Rugby Tour to Promote Sleep Health | - GuruFocus

May 15, 2025
pulisher
May 15, 2025

ResMed named Sleep Partner of the Qatar Airways British & Irish Lions Tour - TipRanks

May 15, 2025
pulisher
May 15, 2025

Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025 - The Spec

May 15, 2025
pulisher
May 15, 2025

Patient Monitoring Stocks Q1 Teardown: ResMed (NYSE:RMD) Vs The Rest - Yahoo Finance

May 15, 2025
pulisher
May 11, 2025

Resmed Inc Updates Dividend Exchange Rate for CDI Holders - TipRanks

May 11, 2025
pulisher
May 09, 2025

Levi & Korsinsky Reminds ResMed Investors of the Ongoing Investigation into Potential Violations of Securities LawsRMD - ACCESS Newswire

May 09, 2025
pulisher
May 09, 2025

ResMed CEO Michael Farrell sells $1.95m in stock By Investing.com - Investing.com Canada

May 09, 2025
pulisher
May 09, 2025

Resmed Insider Sold Shares Worth $1,948,003, According to a Recent SEC Filing - marketscreener.com

May 09, 2025
pulisher
May 09, 2025

ResMed CEO Michael Farrell sells $1.95m in stock - Investing.com

May 09, 2025
pulisher
May 08, 2025

Insider Sell: Peter Farrell Sells 2,000 Shares of ResMed Inc (RMD) - GuruFocus

May 08, 2025
pulisher
May 07, 2025

Resmed prevails over Cleveland Medical in CPAP patent review - BioWorld MedTech

May 07, 2025
pulisher
May 06, 2025

Is ResMed Inc.'s (NYSE:RMD) Latest Stock Performance A Reflection Of Its Financial Health? - simplywall.st

May 06, 2025
pulisher
May 06, 2025

Ex-Dividend Reminder: Seaboard, KB Home and ResMed - Nasdaq

May 06, 2025
pulisher
May 05, 2025

ResMed Inc Reports Changes in CDIs and Securities for April 2025 - TipRanks

May 05, 2025
pulisher
May 05, 2025

Jim Cramer on Viemed Healthcare (VMD): “Interesting, But I’m a ResMed Guy” - Yahoo Finance

May 05, 2025
pulisher
May 05, 2025

ResMed Wins Invalidation of Sleep Apnea Tech Patent After Remand - Bloomberg Law News

May 05, 2025
pulisher
May 03, 2025

Is It Smart To Buy ResMed Inc. (NYSE:RMD) Before It Goes Ex-Dividend? - Yahoo Finance

May 03, 2025
pulisher
May 02, 2025

ResMed Corporation: GLP-1 Demand Generation Strategy to Expand Customer Base & Strengthen Their Position! - Smartkarma

May 02, 2025
pulisher
May 02, 2025

Intuitive wins new FDA nod for single port robot; Resmed buys diagnostic facility - MedTech Dive

May 02, 2025
pulisher
May 02, 2025

This ResMed Insider Reduced Their Stake By 72% - Yahoo Finance

May 02, 2025
pulisher
May 02, 2025

Resmed acquires independent diagnostic testing facility VirtuOx - Yahoo Finance

May 02, 2025

Resmed Inc (RMD) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
medical_instruments_supplies ALC
$86.35
price up icon 1.14%
medical_instruments_supplies BDX
$173.82
price up icon 0.47%
medical_instruments_supplies COO
$79.96
price down icon 0.20%
medical_instruments_supplies BAX
$30.70
price up icon 0.39%
medical_instruments_supplies WST
$210.46
price down icon 0.44%
大文字化:     |  ボリューム (24 時間):